Journal of Hebei Medical College for Continuing Education ›› 2023, Vol. 40 ›› Issue (4): 1-10.DOI: 10.3969/j.issn.1674-490X.2023.04.001
Received:
2023-05-19
Online:
2023-08-25
Published:
2023-08-25
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: //yxyjyjy.hbu.edu.cn/EN/10.3969/j.issn.1674-490X.2023.04.001
[1] ZHANG Y, PROENCA R, MAFFEI M, et al. Positional cloning of the mouse obese gene and its human homologue[J]. Nature, 1994, 372(6505): 425-432. DOI: 10.1038/372425a0. [2] KELESIDIS T, KELESIDIS I, CHOU S, et al. Narrative review: the role of leptin in human physiology: emerging clinical applications[J]. Ann Intern Med, 2010, 152(2): 93-100. DOI: 10.7326/0003-4819-152-2-201001190-00008. [3] KOHLSDORF K, NUNZIATA A, FUNCKE J B, et al. Early childhood BMI trajectories in monogenic obesity due to leptin, leptin receptor, and melanocortin 4 receptor deficiency[J]. Int J Obes(Lond), 2018, 42(9): 1602-1609. DOI: 10.1038/s41366-018-0049-6. [4] KLINE A D, BECKER G W, CHURGAY L M, et al. Leptin is a four-helix bundle: secondary structure by NMR[J]. FEBS Lett, 1997, 407(2): 239-242. DOI: 10.1016/s0014-5793(97)00353-0. [5] REHMAN K, AKASH M S H, ALINA Z. Leptin: a new therapeutic target for treatment of diabetes mellitus[J]. J Cell Biochem, 2018, 119(7): 5016-5027. DOI: 10.1002/jcb.26580. [6] PEREIRA S, CLINE D L, GLAVAS M M, et al. Tissue-specific effects of leptin on glucose and lipid metabolism[J]. Endocr Rev, 2021, 42(1): 1-28. DOI: 10.1210/endrev/bnaa027. [7] MARTÍNEZ-SÁNCHEZ N. There and back again: leptin actions in white adipose tissue[J]. Int J Mol Sci, 2020, 21(17): 6039. DOI: 10.3390/ijms21176039. [8] STEPIEN M, ROSNIAK-BAK K, PARADOWSKI M, et al. Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results[J]. Med Sci Monit, 2011, 17(11): PR13-PR18. DOI: 10.12659/msm.882030. [9] CARO J F, KOLACZYNSKI J W, NYCE M R, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance[J]. Lancet, 1996, 348(9021): 159-161. DOI: 10.1016/s0140-6736(96)03173-x. [10] FAOUZI M, LESHAN R, BJÖRNHOLM M, et al. Differential accessibility of circulating leptin to individual hypothalamic sites[J]. Endocrinology, 2007, 148(11): 5414-5423. DOI: 10.1210/en.2007-0655. [11] MURPHY K T, SCHWARTZ G J, NGUYEN N L, et al. Leptin-sensitive sensory nerves innervate white fat[J]. Am J Physiol Endocrinol Metab, 2013, 304(12): E1338-E1347. DOI: 10.1152/ajpendo.00021.2013. [12] GHADGE A A, KHAIRE A A. Leptin as a predictive marker for metabolic syndrome[J]. Cytokine, 2019, 121: 154735. DOI: 10.1016/j.cyto.2019.154735. [13] BERGER C, KLÖTING N. Leptin receptor compound heterozygosity in humans and animal models[J]. Int J Mol Sci, 2021, 22(9): 4475. DOI: 10.3390/ijms22094475. [14] ZABEAU L, WAUMAN J, DAM J, et al. A novel leptin receptor antagonist uncouples leptin's metabolic and immune functions[J]. Cell Mol Life Sci, 2019, 76(6): 1201-1214. DOI: 10.1007/s00018-019-03004-9. [15] MOHARANA K, ZABEAU L, PEELMAN F, et al. Structural and mechanistic paradigm of leptin receptor activation revealed by complexes with wild-type and antagonist leptins[J]. Structure, 2014, 22(6): 866-877. DOI: 10.1016/j.str.2014.04.012. [16] TSIRIGOTAKI A, DANSERCOER A, VERSCHUEREN K H G, et al. Mechanism of receptor assembly via the pleiotropic adipokine Leptin[J]. Nat Struct Mol Biol, 2023, 30(4): 551-563. DOI: 10.1038/s41594-023-00941-9. [17] ZHANG F M, CHEN Y Y, HEIMAN M, et al. Leptin: structure, function and biology[J]. Vitam Horm, 2005, 71: 345-372. DOI: 10.1016/S0083-6729(05)71012-8. [18] SÉRON K, COUTURIER C, BELOUZARD S, et al. Endospanins regulate a postinternalization step of the leptin receptor endocytic pathway[J]. J Biol Chem, 2011, 286(20): 17968-17981. DOI: 10.1074/jbc.M111.224857. [19] D'SOUZA A M, NEUMANN U H, GLAVAS M M, et al. The glucoregulatory actions of leptin[J]. Mol Metab, 2017, 6(9): 1052-1065. DOI: 10.1016/j.molmet.2017.04.011. [20] TU L L, FUKUDA M, TONG Q C, et al. The ventromedial hypothalamic nucleus: watchdog of whole-body glucose homeostasis[J]. Cell Biosci, 2022, 12(1): 71. DOI: 10.1186/s13578-022-00799-2. [21] DUQUENNE M, FOLGUEIRA C, BOUROUH C, et al. Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function[J]. Nat Metab, 2021, 3(8): 1071-1090. DOI: 10.1038/s42255-021-00432-5. [22] LEE Y H, MAGKOS F, MANTZOROS C S, et al. Effects of leptin and adiponectin on pancreatic β-cell function[J]. Metabolism, 2011, 60(12): 1664-1672. DOI: 10.1016/j.metabol.2011.04.008. [23] BOUCSEIN A, KAMSTRA K, TUPS A. Central signalling cross-talk between insulin and leptin in glucose and energy homeostasis[J]. J Neuroendocrinol, 2021, 33(4): e12944. DOI: 10.1111/jne.12944. [24] LI R J W, ZHANG S Y, LAM T K T. Interaction of glucose sensing and leptin action in the brain[J]. Mol Metab, 2020, 39: 101011. DOI: 10.1016/j.molmet.2020.101011. [25] ZHAO S G, ZHU Y, SCHULTZ R D, et al. Partial leptin reduction as an insulin sensitization and weight loss strategy[J]. Cell Metab, 2019, 30(4): 706-719. DOI: 10.1016/j.cmet.2019.08.005. [26] CHINOOKOSWONG N, WANG J L, SHI Z Q. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat[J]. Diabetes, 1999, 48(7): 1487-1492. DOI: 10.2337/diabetes.48.7.1487. [27] NEUMANN U H, DENROCHE H C, MOJIBIAN M, et al. Insulin knockout mice have extended survival but volatile blood glucose levels on leptin therapy[J]. Endocrinology, 2016, 157(3): 1007-1012. DOI: 10.1210/en.2015-1890. [28] WANG P, LOH K H, WU M, et al. A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue[J]. Nature, 2020, 583(7818): 839-844. DOI: 10.1038/s41586-020-2527-y. [29] VILLANUEVA-CARMONA T, CEDÓL, MADEIRA A, et al. SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression[J]. Cell Metab, 2023, 35(4): 601-619. DOI: 10.1016/j.cmet.2023.03.004. [30] JAUBERT A M, PENOT G, NIANG F, et al. Rapid nitration of adipocyte phosphoenolpyruvate carboxykinase by leptin reduces glyceroneogenesis and induces fatty acid release[J]. PLoS One, 2012, 7(7): e40650. DOI: 10.1371/journal.pone.0040650. [31] PARK Y M, MYERS M, VIEIRA-POTTER V J. Adipose tissue inflammation and metabolic dysfunction: role of exercise[J]. Mo Med, 2014, 111(1): 65-72. [32] PALHINHA L, LIECHOCKI S, HOTTZ E D, et al. Leptin induces proadipogenic and proinflammatory signaling in adipocytes[J]. Front Endocrinol(Lausanne), 2019, 10: 841. DOI: 10.3389/fendo.2019.00841. [33] VUOLTEENAHO K, KOSKINEN A, KUKKONEN M, et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage: mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production[J]. Mediators Inflamm, 2009, 2009: 345838. DOI: 10.1155/2009/345838. [34] ACEDO S C, GAMBERO S, CUNHA F G, et al. Participation of leptin in the determination of the macrophage phenotype: an additional role in adipocyte and macrophage crosstalk[J]. In Vitro Cell Dev Biol Anim, 2013, 49(6): 473-478. DOI: 10.1007/s11626-013-9629-x. [35] LA CAVA A. Proinflammatory activities of leptin in non-autoimmune conditions[J]. Inflamm Allergy Drug Targets, 2012, 11(4): 298-302. DOI: 10.2174/187152812800959031. [36] LUAN B, GOODARZI M O, PHILLIPS N G, et al. Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4[J]. Cell Metab, 2014, 19(6): 1058-1065. DOI: 10.1016/j.cmet.2014.03.024. [37] GAN L, LIU Z, FENG F, et al. Foxc2 coordinates inflammation and browning of white adipose by leptin-STAT3-PRDM16 signal in mice[J]. Int J Obes(Lond), 2018, 42(2): 252-259. DOI: 10.1038/ijo.2017.208. [38] KIGUCHI N, MAEDA T, KOBAYASHI Y, et al. Leptin enhances CC-chemokine ligand expression in cultured murine macrophage[J]. Biochem Biophys Res Commun, 2009, 384(3): 311-315. DOI: 10.1016/j.bbrc.2009.04.121. [39] SOUZA-ALMEIDA G, D'AVILA H, ALMEIDA P E, et al. Leptin mediates in vivo neutrophil migration: involvement of tumor necrosis factor-alpha and CXCL1[J]. Front Immunol, 2018, 9: 111. DOI: 10.3389/fimmu.2018.00111. [40] PROCACCINI C, DE ROSA V, GALGANI M, et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness[J]. Immunity, 2010, 33(6): 929-941. DOI: 10.1016/j.immuni.2010.11.024. [41] PROCACCINI C, DE ROSA V, GALGANI M, et al. Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses[J]. J Immunol, 2012, 189(6): 2941-2953. DOI: 10.4049/jimmunol.1200935. [42] AMARILYO G, IIKUNI N, SHI F D, et al. Leptin promotes lupus T-cell autoimmunity[J]. Clin Immunol, 2013, 149(3): 530-533. DOI: 10.1016/j.clim.2013.09.002. [43] POEGGELER B, SCHULZ C, PAPPOLLA M A, et al. Leptin and the skin: a new frontier[J]. Exp Dermatol, 2010, 19(1): 12-18. DOI: 10.1111/j.1600-0625.2009.00930.x. [44] YUAN C, LIAO J, ZHENG L Y, et al. Current knowledge of leptin in wound healing: a collaborative review[J]. Front Pharmacol, 2022, 13: 968142. DOI: 10.3389/fphar.2022.968142. [45] ZHANG L, LI R, WU B H, et al. Leptin activates the JAK/STAT pathway to promote angiogenesis in RF/6A cells in vitro[J]. Int J Ophthalmol, 2022, 15(4): 554-559. DOI: 10.18240/ijo.2022.04.05. [46] TADOKORO S, IDE S, TOKUYAMA R, et al. Leptin promotes wound healing in the skin[J]. PLoS One, 2015, 10(3): e0121242. DOI: 10.1371/journal.pone.0121242. [47] UMEKI H, TOKUYAMA R, IDE S, et al. Leptin promotes wound healing in the oral mucosa[J]. PLoS One, 2014, 9(7): e101984. DOI: 10.1371/journal.pone.0101984. [48] TANIGAWA T, WATANABE T, OTANI K, et al. Leptin promotes gastric ulcer healing via upregulation of vascular endothelial growth factor[J]. Digestion, 2010, 81(2): 86-95. DOI: 10.1159/000243719. [49] STALLMEYER B, KÄMPFER H, PODDA M, et al. A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair[J]. J Invest Dermatol, 2001, 117(1): 98-105. DOI: 10.1046/j.0022-202x.2001.01387.x. [50] GRÖSCHL M, TOPF H G, KRATZSCH J, et al. Salivary leptin induces increased expression of growth factors in oral keratinocytes[J]. J Mol Endocrinol, 2005, 34(2): 353-366. DOI: 10.1677/jme.1.01658. [51] 李培兵, 金宏, 刘佃辛, 等. 瘦素促进皮肤创伤大鼠胶原合成的实验研究[J]. 中国应用生理学杂志, 2011, 27(1):72-74,132. [52] KOVÁCS D, FAZEKAS F, OLÁH A, et al. Adipokines in the skin and in dermatological diseases[J]. Int J Mol Sci, 2020, 21(23): 9048. DOI: 10.3390/ijms21239048. [53] SŁABUSZEWSKA-JÓZ'WIAK A, LUKASZUK A, JANICKA-KOS'NIK M, et al. Role of leptin and adiponectin in endometrial cancer[J]. Int J Mol Sci, 2022, 23(10): 5307. DOI: 10.3390/ijms23105307. [54] EL-DEEB A M, FANSA H A, WAHBA O M. The expression of leptin in oral wound healing in diabetes mellitus: an experimental study[J]. Int J Health Sci(Qassim), 2018, 12(2): 22-25. [55] ZHAO J Z, LEE K, TOH H C, et al. Unravelling the role of obesity and lipids during tumor progression[J]. Front Pharmacol, 2023, 14: 1163160. DOI: 10.3389/fphar.2023.1163160. [56] AVGERINOS K I, SPYROU N, MANTZOROS C S, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives[J]. Metabolism, 2019, 92: 121-135. DOI: 10.1016/j.metabol.2018.11.001. [57] ZHAO C R, WU M, ZENG N, et al. Cancer-associated adipocytes: emerging supporters in breast cancer[J]. J Exp Clin Cancer Res, 2020, 39(1): 156. DOI: 10.1186/s13046-020-01666-z. [58] FILALI-MOUNCEF Y, HUNTER C, ROCCIO F, et al. The ménage à trois of autophagy, lipid droplets and liver disease[J]. Autophagy, 2022, 18(1): 50-72. DOI: 10.1080/15548627.2021.1895658. [59] XU M, CAO F L, LI N Y, et al. Leptin induces epithelial-to-mesenchymal transition via activation of the ERK signaling pathway in lung cancer cells[J]. Oncol Lett, 2018, 16(4): 4782-4788. DOI: 10.3892/ol.2018.9230. [60] BOWERS L W, ROSSI E L, MCDONELL S B, et al. Leptin signaling mediates obesity-associated CSC enrichment and EMT in preclinical TNBC models[J]. Mol Cancer Res, 2018, 16(5): 869-879. DOI: 10.1158/1541-7786.MCR-17-0508. [61] THIAGARAJAN P S, ZHENG Q, BHAGRATH M, et al. STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance[J]. Endocr Relat Cancer, 2017, 24(8): 415-426. DOI: 10.1530/ERC-16-0349. [62] GORRAB A, PAGANO A, AYED K, et al. Leptin promotes prostate cancer proliferation and migration by stimulating STAT3 pathway[J]. Nutr Cancer, 2021, 73(7): 1217-1227. DOI: 10.1080/01635581.2020.1792946. [63] CAO D X, LUO Y, QIN S L, et al. Metallopanstimulin-1(MPS-1)mediates the promotion effect of leptin on colorectal cancer through activation of JNK/c-Jun signaling pathway[J]. Cell Death Dis, 2019, 10(9): 655. DOI: 10.1038/s41419-019-1911-8. [64] CAMPO-VERDE-ARBOCCO F, LÓPEZ-LAUR J D, ROMEO L R, et al. Human renal adipose tissue induces the invasion and progression of renal cell carcinoma[J]. Oncotarget, 2017, 8(55): 94223-94234. DOI: 10.18632/oncotarget.21666. [65] AMJADI F, MEHDIPOOR R, ZARKESH-ESFAHANI H, et al. Leptin serves as angiogenic/mitogenic factor in melanoma tumor growth[J]. Adv Biomed Res, 2016, 5: 127. DOI: 10.4103/2277-9175.187005. [66] CHEN C, CHANG Y C, LIU C L, et al. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway[J]. Endocr Relat Cancer, 2007, 14(2): 513-529. DOI: 10.1677/ERC-06-0027. [67] RIBATTI D, BELLONI A S, NICO B, et al. Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma[J]. Peptides, 2008, 29(9): 1596-1602. DOI: 10.1016/j.peptides.2008.05.011. [68] KAUSHIK N, KIM S, SUH Y, et al. Proinvasive extracellular matrix remodeling for tumor progression[J]. Arch Pharm Res, 2019, 42(1): 40-47. DOI: 10.1007/s12272-018-1097-0. [69] GHASEMI A, HASHEMY S I, AGHAEI M, et al. Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways[J]. J Cell Biochem, 2018, 119(2): 2333-2344. DOI: 10.1002/jcb.26396. [70] STEFANOU N, PAPANIKOLAOU V, FURUKAWA Y, et al. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase[J]. BMC Cancer, 2010, 10: 442. DOI: 10.1186/1471-2407-10-442. |
[1] | ZHANG Jingbo, SHI Jian, YANG Jingyun, RAN Jipeng, LIU Ziteng, ZHANG Shasha. Correlational analyses between the production of anti-nuclear antibodies and biomarkers of variants intramural hematoma [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(5): 19-24. |
[2] | ZHU Jianping, LI Yunman. The key role of Nrf2 in ischemic stroke [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(2): 1-9. |
[3] | . [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(1): 32-36. |
[4] | . [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(1): 1-11. |
[5] | . [J]. Medical Reserch and Education, 2019, 36(4): 10-18. |
[6] | . [J]. Medical Reserch and Education, 2019, 36(2): 1-7. |
[7] | . [J]. Medical Reserch and Education, 2019, 36(1): 17-23. |
[8] | . [J]. Medical Reserch and Education, 2019, 36(1): 6-12. |
[9] | . [J]. Medical Reserch and Education, 2018, 35(1): 19-24. |
[10] | LI Li,GUO Xintong, CUI Yan,REN Yali,MA Ning,LI Xinbao,NIU Pei. The latest progress of treatment and reconstruction of energy metabolism in heart failure [J]. Medical Reserch and Education, 2015, 32(4): 44-49. |
[11] | MA Jiaqing, YU Meng, ZHANG Haisong. Progress of Strontium on bone mineral metabolism [J]. Medical Reserch and Education, 2015, 32(2): 82-86. |
[12] | . The expression and research progress of Survivin,COX-2 in salivary gland tumors [J]. Medical Reserch and Education, 2013, 30(2): 85-89. |
[13] | . The protective effects of HO-1 induced by pitavastatin on hepatic inflammation and injury caused by ischemia reperfusion in rats [J]. Medical Reserch and Education, 2013, 30(1): 9-14. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||